Along with a panel of experts, IMF Chief Scientific Officer Dr. Brian G.M. Durie will speak on advances in myeloma research from ASCO and EHA.
At the upcoming IMWG Conference Series, “Making Sense of Treatment,” leading myeloma experts will discuss the latest drug therapy news from the June 2024 American Society of Clinical Oncology (ASCO) Annual Conference, IMF IMWG Summit, and the European Hematology Association (EHA) Annual Conference.
IMF Chief Scientific Officer Dr. Brian G.M. Durie will moderate the discussion, with María-Victoria Mateos, MD, PhD (University of Salamanca-Salamanca, Spain) and Thomas Martin, MD (University of California San Francisco-San Francisco, CA) serving as panelists.
The panel and Dr. Durie will then focus on the following topics:
- MGUS and Smoldering Multiple Myeloma (SMM)
- Current Challenges in Multiple Myeloma
- Future Directions of Frontline Therapy
- Immune Therapies (CAR T-cell and Bispecifics) and Next Generation Approaches
- New Myeloma Drugs and Endpoints
- Working Committee Reports
_______________
Improving Lives | Finding the Cure
Founded in 1990, the International Myeloma Foundation (IMF) is the first and largest organization focusing specifically on multiple myeloma. The IMF’s reach extends to more than 525,000 members in 140 countries worldwide. The IMF is dedicated to improving the quality of lives of myeloma patients while working toward prevention and a cure through our four founding principles: Research, Education, Support, and Advocacy.
Subscribe to our channel: / imfmyeloma
Visit our website at: www.myeloma.org
Find us online:
Facebook: @myeloma | / myeloma
Twitter: @IMFMyeloma | / imfmyeloma
Instagram: @imfmyeloma | / imfmyeloma
LinkedIn: / international-myeloma-...
Support the IMF | Donate Now! fundraise.myeloma.org/give/52...
Category
Nonprofits & Activism
License
Standard RU-vid License
In most cases, captions are autogenerated by RU-vid.
20 июн 2024
